Table 2.
Demographic and clinical characteristics of the enrolled patients with the Helicobacter pylori eradication therapies.
| Characteristic | Susceptibility-based Clari-TTa | Empirical therapies |
|||
|---|---|---|---|---|---|
| Clari-TTa | M-BQTb | STc | p-Value | ||
| Total patients | 46 | 90 | 90 | 90 | – |
| Age (years) | 39 ± 15∗ | 38.7 ± 15.6∗ | 37 ± 11.8∗ | 37.1 ± 12.7∗ | 0.64 |
| Sex (male/female) | 17/29 | 28/62 | 42/48 | 39/51 | 0.08 |
| Smoking habit (yes/no) | 9/36 | 11/79 | 14/76 | 22/68 | 0.82 |
| Alcohol consumption (yes/no or less than standard drink) | 8/38 | 12/78 | 11/79 | 17/73 | 0.68 |
∗mean ± SD, aClarithromycin-triple therapy, bmodified bismuth quadruple therapy, csequential therapy.